Flavonoids as prospective compounds for anti-cancer therapy D Ravishankar, AK Rajora, F Greco, HMI Osborn The international journal of biochemistry & cell biology 45 (12), 2821-2831, 2013 | 678 | 2013 |
The asymmetric synthesis of aziridines HMI Osborn, J Sweeney Tetrahedron: Asymmetry 8 (11), 1693-1715, 1997 | 562 | 1997 |
Recent advances in the construction of β-D-mannose and β-D-mannosamine linkages JJ Gridley, HMI Osborn Journal of the Chemical Society, Perkin Transactions 1, 1471-1491, 2000 | 235 | 2000 |
Recent developments in polymer supported syntheses of oligosaccharides and glycopeptides HMI Osborn, TH Khan Tetrahedron 55 (7), 1807-1850, 1999 | 183 | 1999 |
Neoglycolipid probes prepared via oxime ligation for microarray analysis of oligosaccharide-protein interactions Y Liu, T Feizi, MA Campanero-Rhodes, RA Childs, Y Zhang, B Mulloy, ... Chemistry & biology 14 (7), 847-859, 2007 | 165 | 2007 |
One-pot synthesis of multivalent arrays of mannose mono-and disaccharides W Hayes, HMI Osborn, SD Osborne, RA Rastall, B Romagnoli Tetrahedron 59 (40), 7983-7996, 2003 | 144 | 2003 |
Parameters affecting the enhanced permeability and retention effect: the need for patient selection AA Natfji, D Ravishankar, HMI Osborn, F Greco Journal of pharmaceutical sciences 106 (11), 3179-3187, 2017 | 141 | 2017 |
1, 3-dipolar cycloaddition reactions of carbohydrate derived nitrones and oximes HMI Osborn, N Gemmell, LM Harwood Journal of the Chemical Society, Perkin Transactions 1, 2419-2438, 2002 | 138 | 2002 |
A New Strategy for Oligosaccharide Assembly Exploiting Cyclohexane‐1, 2‐diacetal Methodology: An Efficient Synthesis of a High Mannose Type Nonasaccharide P Grice, SV Ley, J Pietruszka, HMI Osborn, HWM Priepke, SL Warriner Chemistry–A European Journal 3 (3), 431-440, 1997 | 124 | 1997 |
Direct preparation of diacetals from 1, 2-diketones and their use as1, 2-diol protecting groups A Hense, SV Ley, HMI Osborn, DR Owen, JF Poisson, SL Warriner, ... Journal of the Chemical Society, Perkin Transactions 1, 2023-2032, 1997 | 113 | 1997 |
Carbohydrate‐based therapeutics HMI Osborn, PG Evans, N Gemmell, SD Osborne Journal of pharmacy and pharmacology 56 (6), 691-702, 2004 | 93 | 2004 |
Melanocyte-directed enzyme prodrug therapy (MDEPT): Development of second generation prodrugs for targeted treatment of malignant melanoma AM Jordan, TH Khan, H Malkin, HMI Osborn, A Photiou, PA Riley Bioorganic & medicinal chemistry 9 (6), 1549-1558, 2001 | 77 | 2001 |
Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells RE Owen, E Yamada, CI Thompson, LJ Phillipson, C Thompson, E Taylor, ... Journal of virology 81 (20), 11170-11178, 2007 | 75 | 2007 |
Regioselective C-3-O-acylation and O-methylation of 4, 6-O-benzylidene-β-D-gluco-and galactopyranosides displaying a range of anomeric substituents HMI Osborn, VA Brome, LM Harwood, WG Suthers Carbohydrate research 332 (2), 157-166, 2001 | 73 | 2001 |
Oligosaccharides: their synthesis and biological roles HMI Osborn, TH Khan Oxford University Press on Demand, 2000 | 73 | 2000 |
Melanocyte-directed enzyme prodrug therapy (MDEPT): development of a targeted treatment for malignant melanoma AM Jordan, TH Khan, HMI Osborn, A Photiou, PA Riley Bioorganic & medicinal chemistry 7 (9), 1775-1780, 1999 | 72 | 1999 |
Analysis of polysaccharides and monosaccharides in the root mucilage of maize (Zea mays L.) by gas chromatography HMI Osborn, F Lochey, L Mosley, D Read Journal of Chromatography A 831 (2), 267-276, 1999 | 71 | 1999 |
Preparation and ring-opening reactions of N-diphenylphosphinyl aziridines AA Cantrill, HMI Osborn, J Sweeney Tetrahedron 54 (10), 2181-2208, 1998 | 70 | 1998 |
Exploring quercetin and luteolin derivatives as antiangiogenic agents D Ravishankar, KA Watson, SY Boateng, RJ Green, F Greco, HMI Osborn European journal of medicinal chemistry 97, 259-274, 2015 | 69 | 2015 |
Tyrosinase activated melanoma prodrugs S Jawaid, TH Khan, HMI Osborn, NAO Williams Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2009 | 67 | 2009 |